eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Abstracting and indexing Subscription Contact Instructions for authors
vol. 9
Original paper

Management of healthcare-associated infections at the end of life – a cross-sectional study

Tomasz Grądalski, Barbara Burczyk-Fitowska

Medycyna Paliatywna 2017; 9(3): 152–156
Online publish date: 2018/02/01
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
A retrospective chart review was performed on 1458 patients admitted to the free-standing hospice between 1 September 2013 and 31 January 2016. A total of 134 (9.2%) patients (123 with advanced cancer) were clinically diagnosed with 172 cases of various healthcare-associated infections (HAI): two, three, and four times in 26, 5, and 1 person/s, respectively. The median length of care within the infected group was 32.0 days (vs. 9.6 days for non-infected). The most prominent infection risk factors identified were prolonged steroid therapy (37.0% of episodes), antibiotics used before the admission (23.7%), and bladder catheterisation (23.9%). The most common types of HAI were lower respiratory tract infection (LRTI; 43.0%), end-of-life infection of unknown origin (EOL-IUO), urinary tract infection (UTI) (17.4% each), and Clostridium difficile-associated diarrhoea (9.9%). Antibiotics most often used were gentamicin (once-only dosage) in EOL-PUO (27.9% of episodes), ceftriaxone in LRTI (17.4%), and levofloxacin in UTI (15.7%). In 18.0% of cases a sequence of two antibiotics was required. In 4.0% of episodes a sole symptomatic therapy was continued. Clinically meaningful improvement after the full course of antimicrobials was achieved in 79.5% of cases. Once-only antimicrobial was still efficacious but less so (52.1%, p = 0.0006) and comparable with sole symptomatic treatment (p = 0.7). The cost of antibiotics was 16.7% of all drug expenses. Antibiotic therapy appeared to be a frequently chosen, effective although expensive symptomatic management at the end of life.

infections, antimicrobials, palliative care

Homsi J, Walsh D, Panta R, et al. Infectious complications of advanced cancer. Support Care Cancer 2000; 8: 487-492.
Chun ED, Rodgers PE, Vitale CA, et al. Antimicrobial use among patients receiving palliative care consultation. Am J Hosp Palliat Care 2010; 27: 261-265.
Thompson AJ, Silveira MJ, Vitale CA, et al. Antimicrobial use at the end of life among hospitalized patients with advanced cancer. Am J Hosp Palliat Care 2012; 29: 599-603.
Yates E, Mitchell SL, Habtemariam D, et al. Interventions Associated With the Management of Suspected Infections in Advanced Dementia. J Pain Symptom Manage 2015; 50: 806-813.
Stosor V, Zembower TR (eds.). Infectious Complications in Cancer Patients. Cancer Treatment and Research. Springer International Publishing, Cham 2014.
Gold Standards Framework. Retrieved from: http://www.goldstandardsframework.org.uk/.
Stone ND, Ashraf MS, Calder J, et al. Surveillance Definitions of Infections in Long-Term Care Facilities: Revisiting the McGeer Criteria. Infect Control Hosp Epidemiol 2012; 33: 965-977.
Wójkowska-Mach J, Gryglewska B, Grodzicki T, et al. Definitions of infection in acute care hospitals and in long term care facilities. Gerontol Pol 2010; 18: 10-15.
Gutmanis I, Shadd J, Woolmore-Goodwin S, et al. Prevalence and indications for bladder catheterization on a palliative care unit: a prospective, observational study. Palliat Med 2014; 28: 1239-1240.
Wójkowska-Mach J, Gryglewska B, Czekaj J, et al. Infection control: point prevalence study versus incidence study in Polish long-term care facilities in 2009–2010 in the Małopolska Region. Infection 2013; 41: 1-8.
Nagy-Agren S, Haley HB. Management of infections in palliative care patients with advanced cancer. J Pain Symptom Manage 2002; 24: 64-70.
Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000; 20: 326-334.
Thai V, Lau F, Wolch G, et al. Impact of infections on the survival of hospitalized advanced cancer patients. J Pain Symptom Manage 2012; 43: 549-557.
White PH, Kuhlenschmidt HL, Vancura BG, et al. Antimicrobial use in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2003; 25: 438-443.
Mitchel BG, Ferguson JK, Anderson M, et al. Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hospital Infection 2016; 93: 92-99.
Yajima R, Ise Y, Wako T, et al. A Retrospective Study of Risk Factors for Infection in Cancer Patients Receiving Specialist Palliative Care. J Nippon Med Sch 2013; 80: 481-485.
Wójkowska-Mach J, Gryglewska B, Romaniszyn D, et al. Age and other risk factors of pneumonia among residents of Polish long-term care facilities. Int J Infect Dis 2013; 17: e37-e43.
Homsi J, Walsh D, Panta R, et al. Infectious complications of advanced cancer. Support Care Cancer 2000; 8: 487-492.
Yu H, Baser O, Wang L. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. Geriatrics 2016; 16: 193.
Thipmontree W, Kiratisin P, Manatsathit S, et al. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital. J Med Assoc Thai 2011; 94 Suppl 1: S207-216.
Toussaint E, Bahel-Ball E, Vekemans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer 2006; 14: 763-769.
Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 1994; 120: 827-833.
Schmalz O, Strapatsas T, Alefelder C, et al. Methicillin-resistant Staphylococcus aureus in palliative care: A prospective study of Methicillin-resistant Staphylococcus aureus prevalence in a hospital-based palliative care unit. Palliat Med 2016; 30: 703-706.
van Nordennen RT, Lavrijsen JC, Vissers KC, et al. Decision Making About Change of Medication for Comorbid Disease at the End of Life: An Integrative Review. Drugs Aging 2014; 31: 501-512.
Szczerbińska K. Quality of palliative care in long-term care facilities in Poland. Results from the PACE study 1. International Conference “End-of-life care for older people in long-term care facilities” 31.03-1.04.2017 Kraków.
Albrecht JS, McGregor JC, Fromme EK, et al. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage 2013; 46: 483-490.
Rosenberg JH, Albrecht JS, Fromme EK, et al. Antimicrobial Use for Symptom Management in Patients Receiving Hospice and Palliative Care: A Systematic Review. J Palliat Med 2013; 16: 1568-1574.
Helde-Frankling M, Bergqvist J, Bergman P, et al. Antibiotic Treatment in End-of-Life Cancer Patients – A Retrospective Observational Study at a Palliative Care Center in Sweden. Cancers 2016; 8: 84.
Merel SE, Meier CA, McKinney CM, et al. Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study J Palliat Med. 2016; 19: 1210-1214.
Schwartz DN, Abiad H, DeMarais PL, et al. An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. J Am Geriatr Soc 2007; 55: 1236-1242.
Scales K, Zimmerman S, Reed D, et al. Nurse and Medical Provider Perspectives on Antibiotic Stewardship in Nursing Homes. J Am Geriatr Soc 2016; 65: 165-171.
Ford PJ, Fraser TG, Davis MP, et al. Ati-infective therapy at end of life: Ethical decision-making in hospice-eligible patients. Bioethics 2005; 19: 379-392.
Twycross R, Wilcock A, Hoard P (eds.). Palliative Care Formulary (5th ed). Retrieved from: palliativedrugs.com.
Spurling GKP, DelMar CB, Dooley L, et al. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2013; CD004417, doi: 10.1002/14651858.CD004417.pub4.
Alsirafy SA, El Mesidy SM, Abou-Elela EN, et al. Naproxen test for neoplastic fever may reduce suffering. J Palliat Med 2011; 14: 665-667.
Reinbolt RE, Shenk AM, White PH, et al. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005; 30: 175-182.
Givens JL, Jones RN, Shaffer ML, et al. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010; 170: 1102-1107.
Clayton J, Fardell B, Hutton-Potts J, et al. Parenteral antibiotics in a palliative care unit: prospective analysis of current practice. Palliat Med 2003; 17; 44-48.
Spruyt O, Kausae A. Antibiotic use for infective terminal respiratory Secretions (letter). J Pain Symptom Manage 1998; 15: 263-264.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe